Crawford faces obstacles in nomination process

Lester Crawford's nomination to head the FDA won committee approval on Wednesday but is still facing some major hurdles before reaching a full Senate vote.
Although the Senate committee on Health, Education, Labor and Pensions approved the nomination, Sens. Patty Murray, D-Wash., and Hillary Clinton, D-N.Y., have placed a hold on Crawford's nomination, blocking immediate consideration of it.
The hold will remain in place until the FDA issues a yes or no decision on allowing OTC sales of Barr Pharmaceuticals' emergency contraceptive Plan B. In January, an FDA advisory panel recommended 24-3 in favor of OTC status for the drug but at press time the agency had yet to make a final determination on the matter.
You must be a registered member of MMM to post a comment.

Content marketing is not advertising in the old sense. In its use of social media, content marketing challenges consumers while relying on their input. It is proactive and responsive to their concerns, needs and energy. Content marketing has become the new voice of marketing. Learn what you need to know and how pharma marketers can adapt to this innovative venture into social media by clicking here for access.

Email Newsletters